XML 52 R41.htm IDEA: XBRL DOCUMENT
v3.25.1

Acquisition - Pro Forma Results (Details) - Zoetis Inc Medicated Feed Additive Product Portfolio - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended
--- | --- | ---
Mar. 31, 2025 | Mar. 31, 2024 | Mar. 31, 2025 | Mar. 31, 2024
Business acquisition, pro forma information |  |  |  |
Net sales | $ 347,825 | $ 354,252 | $ 1,067,875 | $ 1,043,063
Operating income | $ 33,515 | $ 38,697 | $ 120,145 | $ 79,221

X
- Definition Business Acquisition, Pro Forma Operating Income (Loss) + References No definition available. + Details
Name: | pahc_BusinessAcquisitionProFormaOperatingIncomeLoss
Namespace Prefix: | pahc_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_BusinessAcquisitionProFormaInformationAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2 + Details
Name: | us-gaap_BusinessAcquisitionsProFormaRevenue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=pahc_ZoetisIncMedicatedFeedAdditiveProductPortfolioMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |